Reproducing
the structure and function of biological membrane channels,
synthetic nanopores have been developed for applications in membrane
filtration technologies and biomolecular sensing. Stable stand-alone
synthetic nanopores have been created from a variety of materials,
including peptides, nucleic acids, synthetic polymers, and solid-state
membranes. In contrast to biological nanopores, however, furnishing
such synthetic nanopores with an atomically defined shape, including
deliberate placement of each and every chemical group, remains a major
challenge. Here, we introduce a chemosynthetic macromoleculeextended
pillararene macrocycle (EPM)as a chemically defined transmembrane
nanopore that exhibits selective transmembrane transport. Our ionic
current measurements reveal stable insertion of individual EPM nanopores
into a lipid bilayer membrane and remarkable cation type-selective
transport, with up to a 21-fold selectivity for potassium over sodium
ions. Taken together, direct chemical synthesis offers a path to de novo design of a new class of synthetic nanopores with
custom transport functionality imprinted in their atomically defined
chemical structure.
The sequencing of single protein molecules using nanopores is faced with a huge challenge due to the lack of resolution needed to resolve single amino acids. Here we report the direct experimental identification of single amino acids in nanopores. With atomically engineered regions of sensitivity comparable to the size of single amino acids, MoS2 nanopores provide a sub-1 Dalton resolution for discriminating the chemical group difference of single amino acids, including recognizing the amino acid isomers. This ultra-confined nanopore system is further used to detect the phosphorylation of individual amino acids, demonstrating its capability for reading post-translational modifications. Our study suggests that a sub-nanometer engineered pore has the potential to be applied in future chemical recognition and de novo protein sequencing at the single-molecule level.
Titanium (Ti) and its alloys have been widely used in clinics for years. However, their bio-inert surface challenges application in patients with compromised surgical conditions. Numerous studies were conducted to modify the surface topography and chemical composition of Ti substrates, for the purpose of obtaining antibacterial, angiogenic, and osteogenic activities. In this study, using green electrophoretic deposition method, we fabricated gap-bridging chitosan-gelatin (CSG) nanocomposite coatings incorporated with different amounts of copper (Cu; 0.01, 0.1, 1, and 10 mM for Cu I, II, III, and IV groups, respectively) on the Ti substrates. Physicochemical characterization of these coatings confirmed that Cu ions were successfully deposited into the coatings in a metallic status. After rehydration, the coatings swelled by 850% in weight. Mechanical tests verified the excellent tensile bond strength between Ti substrates and deposited coatings. All Cu-containing CSG coatings showed antibacterial property against both Gram-negative
Escherichia coli
and Gram-positive
Staphylococcus aureus
. The antibacterial property was positively correlated with the Cu concentration. In vitro cytocompatibility evaluation demonstrated that activities of bone marrow stromal cells were not impaired on Cu-doped coatings except for the Cu IV group. Moreover, enhanced angiogenic and osteogenic activities were observed on Cu II and Cu III groups. Overall, our results suggested that Cu-doped CSG nanocomposite coating is a promising candidate to functionalize Ti materials with antibacterial, angiogenic, and osteogenic properties.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.